Skip to main content
Clinical Trials/NCT04886414
NCT04886414CompletedNot Applicable

Implementation and Evaluation of Home-based Care and Hand Hygiene Interventions in Honduras

Brigham and Women's Hospital1 site in 1 country1,821 target enrollmentStarted: March 31, 2022Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
1,821
Locations
1
Primary Endpoint
Duration of hospitalization

Study Overview

Brief Summary

This study aims to enroll patients with acute infection with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) who do not meet criteria for hospital admission according to protocols developed by the Honduras Ministry of Health (MOH). Patients who are triaged to home must also be over the age of 60 years or have one high risk comorbidity and be over 45 years in order to meet inclusion criteria. These patients will be randomly assigned to one of four home-based care strategies, which may or may not include regular blood oxygenation monitoring and provision of alcohol-based hand-rub. Patients will be followed until resolution of their acute illness, and data will be collected on feasibility, impact and acceptance of the intervention. Some patients will be followed for up to one year to monitor for post-Coronavirus Disease 2019 (COVID-19) symptoms.

Detailed Description

Rationale:

This project is intended to enhance the existing MOH home-based care approach by providing additional resources and monitoring for patients with COVID-19 that are triaged to Home-based care (HBC) by MOH triage clinicians. In addition, given limited data on which home-based care strategies most effectively and efficiently minimize poor outcomes, we aim to monitor four discrete home-based care approaches. Assignment to home-based care approach will be randomized. Given the primary goal of the project is to reduce morbidity and mortality due to the COVID-19 pandemic, we will not include a control arm.

Setting:

The project location will be the designated municipalities in Honduras. Activities will be conducted in the existing MOH triage (known by the Spanish acronym for Temporary Triage and Stabilization Centers: "CETTE's") and other health centers. Selection of target centers will be performed in collaboration with the Honduras MOH and based on criteria including current and projected COVID-19 hotspots, mortality data and logistical considerations including access and security.

Project Population:

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Factorial
Primary Purpose
Health Services Research
Masking
None

Eligibility Criteria

Ages
45 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Duration of hospitalization

Time Frame: 90 days

Duration of hospitalization (days) for those who are admitted

Disposition after referral

Time Frame: 28 days

Disposition (home, admission, other) for those referred to a higher level of care

Duration of ICU and/or ventilator requirement

Time Frame: 90 days

Duration of ICU and/or ventilator requirement (days) for those requiring critical care

Mortality

Time Frame: 90 days

Death prior to discharge from acute COVID-19 monitoring

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Eric J. Nilles, M.D.,M.S.C.

Assistant Professor

Brigham and Women's Hospital

Study Sites (1)

Loading locations...

Similar Trials